Is there a role for the glycemic index in coronary heart disease prevention or treatment?

Area of Science:

• Nutrition Science
• Cardiovascular Health
• Dietary Interventions

Background:

• The clinical utility of the glycemic index (GI) in managing chronic diseases remains debated.
• Evidence linking low-GI diets to reduced coronary heart disease (CHD) outcomes is inconclusive.
• Observational studies present conflicting data regarding low-GI diets and CHD risk factors.

Purpose of the Study:

• To evaluate the effectiveness of low-glycemic index (GI) diets in the prevention and treatment of chronic diseases, particularly CHD.
• To synthesize current evidence on the impact of low-GI diets on CHD mortality, events, morbidity, and associated risk factors.

Main Methods:

• Review of observational studies examining the association between low-GI diets and CHD.
• Analysis of randomized clinical trials comparing low-GI diets with high-GI diets.
• Assessment of effects on total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, insulin, and body weight.

Main Results:

• No evidence supports low-GI diets for reducing CHD mortality, events, or morbidity.
• Randomized trials showed a minor reduction in total cholesterol (-6.6 mg/dL) with low-GI diets.
• No significant reductions were observed in other risk factors, including LDL, HDL, triglycerides, glucose, insulin, or body weight.

Conclusions:

• Current research indicates a minimal role for low-glycemic index (GI) diets in the prevention or treatment of coronary heart disease (CHD).
• The clinical application of GI diets for chronic disease management requires further investigation and validation.